Inflammation Partially Mediates the Association of Multimorbidity and Functional Limitations in a National Sample of Middle-Aged and Older Adults

Abstract

Objective: Older adults are increasingly likely to have two or more chronic medical conditions (multimorbidity) and are consequently at greater risk of disability. Here we examine the role of inflammation in mediating the relationship between multimorbidity and disability. Method: Data are from the Survey of Mid-Life in the United States (MIDUS), a national sample of middle-aged and older adults. Structural equation models were used to assess direct relationships between multimorbidity and activities of daily living as well as indirect associations with a latent variable for inflammation (indicated by circulating levels of interleukin-6, C-reactive protein, and fibrinogen) as a mediator. Results: After adjustment for potential confounds, multimorbidity was positively associated with inflammation (p < .001) and functional limitations (p < .001), and inflammation partially mediated the link between multimorbidity and functional limitations (p < .01). Discussion: Inflammation may be an important biological mechanism through which chronic medical conditions are linked to disability in later life.

Keywords

multimorbidity inflammation disability MIDUS

Get full access to this article

View all access options for this article.

References

Adler

N. E.

Boyce

Chesney

M. A.

Cohen

Folkman

Kahn

R. L.

Syme

S. L.

(1994). Socioeconomic status and health: The challenge of the gradient. American Psychologist, 49, 15-24.

Anderson

Horvath

(2004). The growing burden of chronic disease in America. Public Health Reports, 119, 263-270. doi:10.1016/j.phr.2004.04.005

Arbuckle

J. L.

(1996). Full information estimation in the presence of incomplete data. Mahwah, NJ: Lawrence Erlbaum.

Bastard

J. P.

Maachi

Lagathu

Kim

M. J.

Caron

Vidal

. . . Feve

(2006). Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network, 17(1), 4-12.

Bautista

L. E.

Vera

L. M.

Arenas

I. A.

Gamarra

(2005). Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. Journal of Human Hypertension, 19, 149-154. doi:10.1038/sj.jhh.1001785

Binder

(1983). On the variance of asymptotically normal estimators from complex surveys. International Statistics Review, 51, 279-292.

Blake

G. J.

Ridker

P. M.

(2003). C-reactive protein and other inflammatory risk markers in acute coronary syndromes. Journal of the American College of Cardiology, 41(4 Suppl. 1), S37-S42.

Brinkley

T. E.

Leng

Miller

M. E.

Kitzman

D. W.

Pahor

Berry

M. J.

. . . Nicklas

B. J.

(2009). Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 64, 455-461. doi:10.1093/gerona/gln038

Buchman

A. S.

Boyle

P. A.

Shah

R. C.

Bennett

D. A.

(2012). Total daily physical activity and longevity in old age. Archives of Internal Medicine, 172, 444-446. doi:10.1001/archinternmed.2011.1477

10.

Cesari

Landi

Vellas

Bernabei

Marzetti

(2014). Sarcopenia and physical frailty: Two sides of the same coin. Frontiers in Aging Neuroscience, 6, 192. doi:10.3389/fnagi.2014.00192

11.

Cesari

Penninx

B. W.

Pahor

Lauretani

Corsi

A. M.

Rhys Williams

. . . Ferrucci

(2004). Inflammatory markers and physical performance in older persons: The InCHIANTI study. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 59, 242-248.

12.

Charlson

M. E.

Pompei

Ales

K. L.

MacKenzie

C. R.

(1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373-383.

13.

Cohen

H. J.

Pieper

C. F.

Harris

Rao

K. M.

Currie

M. S.

(1997). The association of plasma IL-6 levels with functional disability in community-dwelling elderly. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 52(4), M201-M208.

14.

Colbert

L. H.

Visser

Simonsick

E. M.

Tracy

R. P.

Newman

A. B.

Kritchevsky

S. B.

. . . Harris

T. B.

(2004). Physical activity, exercise, and inflammatory markers in older adults: Findings from the Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 52, 1098-1104. doi:10.1111/j.1532-5415.2004.52307.x

15.

Diederichs

Berger

Bartels

D. B.

(2011). The measurement of multiple chronic diseases—A systematic review on existing multimorbidity indices. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 66, 301-311. doi:10.1093/gerona/glq208

16.

d’Orsi

Xavier

A. J.

Steptoe

de Oliveira

Ramos

L. R.

Orrell

. . . Marmot

M. G.

(2014). Socioeconomic and lifestyle factors related to instrumental activity of daily living dynamics: Results from the English longitudinal study of ageing. Journal of the American Geriatrics Society, 62, 1630-1639. doi:10.1111/jgs.12990

17.

DuGoff

E. H.

Canudas-Romo

Buttorff

Leff

Anderson

G. F.

(2014). Multiple chronic conditions and life expectancy: A life table analysis. Medical Care, 52, 688-694. doi:10.1097/mlr.0000000000000166

18.

Ershler

W. B.

Keller

E. T.

(2000). Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine, 51, 245-270.

19.

Fabbri

Zoli

Simonsick

E. M.

Guralnik

J. M.

Bandinelli

. . . Ferrucci

(2014). Aging and the burden of multimorbidity: Associations with inflammatory and anabolic hormonal biomarkers. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 70, 63-70. doi:10.1093/gerona/glu127

20.

Ferrucci

Corsi

Lauretani

Bandinelli

Bartali

Taub

D. D.

. . . Longo

D. L.

(2005). The origins of age-related proinflammatory state. Blood, 105, 2294-2299.

21.

Ferrucci

Harris

T. B.

Guralnik

J. M.

Tracy

R. P.

Corti

M. C.

Cohen

H. J.

. . . Havlik

R. J.

(1999). Serum IL-6 level and the development of disability in older persons. Journal of the American Geriatrics Society, 47, 639-646.

22.

Ferrucci

Penninx

B. W.

Volpato

Harris

T. B.

Bandeen-Roche

Balfour

. . . Guralnik

J. M.

(2002). Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. Journal of the American Geriatrics Society, 50, 1947-1954.

23.

Fortin

Hudon

Haggerty

Akker

Almirall

(2010). Prevalence estimates of multimorbidity: A comparative study of two sources. BMC Health Services Research, 10, Article 111. doi:10.1186/1472-6963-10-111

24.

Fortin

Stewart

Poitras

M. E.

Almirall

Maddocks

(2012). A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Annals of Family Medicine, 10, 142-151. doi:10.1370/afm.1337

25.

Friedman

E. M.

Ryff

C. D.

(2012). Living well with medical comorbidities: A biopsychosocial perspective. The Journals of Gerontology, Series B: Psychological Sciences & Social Sciences, 67, 535-544. doi:10.1093/geronb/gbr152

26.

Gruenewald

T. L.

Cohen

Matthews

K. A.

Tracy

Seeman

T. E.

(2009). Association of socioeconomic status with inflammation markers in black and white men and women in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Social Science & Medicine, 69, 451-459. doi:10.1016/j.socscimed.2009.05.018

27.

Hardy

S. E.

McGurl

D. J.

Studenski

S. A.

Degenholtz

H. B.

(2010). Biopsychosocial characteristics of community-dwelling older adults with limited ability to walk one-quarter of a mile. Journal of the American Geriatrics Society, 58, 539-544. doi:10.1111/j.1532-5415.2010.02727.x

28.

Howcroft

T. K.

Campisi

Louis

G. B.

Smith

M. T.

Wise

Wyss-Coray

. . . Sierra

(2013). The role of inflammation in age-related disease. Aging, 5, 84-93.

29.

F. B.

Meigs

J. B.

T. Y.

Rifai

Manson

J. E.

(2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53, 693-700.

30.

Institute of Medicine. (2012). Living well with chronic illness: A call for public health action. Washington, DC: National Academies Press.

31.

Jousilahti

Salomaa

Rasi

Vahtera

Palosuo

(2003). Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. Journal of Epidemiology & Community Health, 57, 730-733.

32.

Katz

J. N.

Chang

L. C.

Sangha

Fossel

A. H.

Bates

D. W.

(1996). Can comorbidity be measured by questionnaire rather than medical record review? Medical Care, 34, 73-84.

33.

Krabbe

K. S.

Pedersen

Bruunsgaard

(2004). Inflammatory mediators in the elderly. Experimental Gerontology, 39, 687-699.

34.

Kriegsman

D. M.

Penninx

B. W.

van Eijk

J. T.

Boeke

A. J.

Deeg

D. J.

(1996). Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. Journal of Clinical Epidemiology, 49, 1407-1417. doi:10.1016/S0895-4356(96)00274-0

35.

Kuo

H. K.

Bean

J. F.

Yen

C. J.

Leveille

S. G.

(2006). Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 61, 380-387.

36.

Lakoski

S. G.

Cushman

Criqui

Rundek

Blumenthal

R. S.

D’Agostino

R. B.

Jr. Herrington

D. M.

(2006). Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. American Heart Journal, 152, 593-598. doi:10.1016/j.ahj.2006.02.015

37.

Landi

Liperoti

Russo

Capoluongo

Barillaro

Pahor

. . . Onder

(2010). Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. Journal of Clinical Epidemiology, 63, 752-759. doi:10.1016/j.jclinepi.2009.09.007

38.

Love

G. D.

Seeman

T. E.

Weinstein

Ryff

C. D.

(2010). Bioindicators in the MIDUS National study: Protocol, measures, sample, and comparative context. Journal of Aging and Health, 22, 1059-1080.

39.

MacKinnon

D. P.

Fairchild

A. J.

Fritz

M. S.

(2007). Mediation analyses. Annual Review of Psychology, 58, 593-614.

40.

Marengoni

Angleman

Melis

Mangialasche

Karp

Garmen

. . . Fratiglioni

(2011). Aging with multimorbidity: A systematic review of the literature. Ageing Research Reviews, 10, 430-439. doi:10.1016/j.arr.2011.03.003

41.

Marengoni

von Strauss

Rizzuto

Winblad

Fratiglioni

(2009). The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. Journal of Internal Medicine, 265, 288-295. doi:10.1111/j.1365-2796.2008.02017.x

42.

Marsland

A. L.

McCaffery

J. M.

Muldoon

M. F.

Manuck

S. B.

(2010). Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism, 59, 1801-1808. doi:10.1016/j.metabol.2010.05.015

43.

McCaffery

J. M.

Marsland

A. L.

Strohacker

Muldoon

M. F.

Manuck

S. B.

(2012). Factor structure underlying components of allostatic load. PLoS ONE, 7(10), e47246. doi:10.1371/journal.pone.0047246

44.

Michaud

Balardy

Moulis

Gaudin

Peyrot

Vellas

. . . Nourhashemi

(2013). Proinflammatory cytokines, aging, and age-related diseases. Journal of the American Medical Directors Association, 14, 877-882. doi:10.1016/j.jamda.2013.05.009

45.

Murtagh

K. N.

Hubert

H. B.

(2004). Gender differences in physical disability among an elderly cohort. American Journal of Public Health, 94, 1406-1411.

46.

Naugler

W. E.

Karin

(2008). The wolf in sheep’s clothing: The role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine, 14, 109-119. doi:10.1016/j.molmed.2007.12.007

47.

Oehlert

G. W.

(1992). A note on the delta method. American Statistician, 46, 27-29.

48.

Pate

R. R.

Pratt

Blair

S. N.

Haskell

W. L.

Macera

C. A.

Bouchard

… Wilmore

J. H.

(1995). Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. Journal of the American Medical Association, 273, 402-407.

49.

Peake

Della Gatta

Cameron-Smith

(2010). Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 298, R1485-R1495. doi:10.1152/ajpregu.00467.2009

50.

Pearson

T. A.

Mensah

G. A.

Alexander

R. W.

Anderson

J. L.

Cannon

R. O.

III Criqui

. . . Vinicor

(2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511.

51.

Rigdon

E. E.

(1994). Demonstrating the effects of unmodeled random measurement error. Structural Equation Modeling, 1, 375-380.

52.

Rothrock

N. E.

Hays

R. D.

Spritzer

Yount

S. E.

Riley

Cella

(2010). Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). Journal of Clinical Epidemiology, 63, 1195-1204. doi:10.1016/j.jclinepi.2010.04.012

53.

Schneider

K. M.

O’Donnell

B. E.

Dean

(2009). Prevalence of multiple chronic conditions in the United States’ Medicare population. Health and Quality of Life Outcomes, 7, Article 82. doi:10.1186/1477-7525-7-82

54.

Schoeni

R. F.

Martin

L. G.

Andreski

P. M.

Freedman

V. A.

(2005). Persistent and growing socioeconomic disparities in disability among the elderly: 1982-2002. American Journal of Public Health, 95, 2065-2070. doi:10.2105/ajph.2004.048744

55.

St. John

P. D.

Tyas

S. L.

Menec

Tate

(2014). Multimorbidity, disability, and mortality in community-dwelling older adults. Canadian Family Physician/Medecin de famille canadien, 60(5), e272-e280.

56.

Taaffe

D. R.

Harris

T. B.

Ferrucci

Rowe

Seeman

T. E.

(2000). Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences, 55(12), M709-M715.

57.

Thacker

S. B.

Stroup

D. F.

Carande-Kulis

Marks

J. S.

Roy

Gerberding

J. L.

(2006). Measuring the public’s health. Public Health Reports, 121, 14-22.

58.

Tinetti

M. E.

McAvay

G. J.

Chang

S. S.

Newman

A. B.

Fitzpatrick

A. L.

Fried

T. R.

Peduzzi

P. N.

(2011). Contribution of multiple chronic conditions to universal health outcomes. Journal of the American Geriatrics Society, 59, 1686-1691. doi:10.1111/j.1532-5415.2011.03573.x

59.

Verbrugge

L. M.

Jette

A. M.

(1994). The disablement process. Social Science & Medicine, 38, 1-14.

60.

Ward

B. W.

Schiller

J. S.

(2013). Prevalence of multiple chronic conditions among US adults: Estimates from the National Health Interview Survey, 2010. Preventing Chronic Disease, 10, Article E65. doi:10.5888/pcd10.120203

61.

Wolff

J. L.

Starfield

Anderson

(2002). Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Archives of Internal Medicine, 162, 2269-2276.

62.

Wolinsky

F. D.

Bentler

S. E.

Hockenberry

Jones

M. P.

Obrizan

Weigel

P. A.

. . . Wallace

R. B.

(2011). Long-term declines in ADLs, IADLs, and mobility among older Medicare beneficiaries. BMC Geriatrics, 11, Article 43. doi:10.1186/1471-2318-11-43